Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06746012 · ClinicalTrials.gov registry record · NA
Designing a Dyad-Based MHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
A NA study of Stage III Rectal Cancer AJCC v8 and Stage II Rectal Cancer AJCC v8, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06746012 is a NA study of Stage III Rectal Cancer AJCC v8 and Stage II Rectal Cancer AJCC v8 that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 70 participants, below the 112-participant average among 15 other Stage III Rectal Cancer AJCC v8 trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06746012, a NA study of Stage III Rectal Cancer AJCC v8 and Stage II Rectal Cancer AJCC v8, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial develops and tests a mobile health (mHealth) intervention to improve adherence to lifestyle recommendations in colorectal cancer (CRC) survivors and their family caregivers. The current challenge for cancer survivorship is identifying novel approaches to help adhere to the lifestyle recommendations that have been shown to improve symptom burden, health outcomes, and health-related quality of life (HRQoL). The development of a digital health intervention specifically for CRC survivors and family caregivers may improve adherence to the American Cancer Society Nutrition and Physical Activity Guideline for Cancer Survivors and improve family health.
Conditions Studied
Interventions
- OTHER Interview
- OTHER Internet-Based Intervention
- PROCEDURE Discussion
- OTHER Educational Activity
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-05-03 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06746012
The ClinicalTrials.gov registry entry for NCT06746012 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 15 other Stage III Rectal Cancer AJCC v8 trials with a reported enrollment target (37% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Stage III Rectal Cancer AJCC v8 appearing as the primary indexed condition, and to 4 interventions - of which Interview is the first listed.
NCT06746012 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06746012 about?
NCT06746012 is a clinical study titled "Designing a Dyad-Based MHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers". This clinical trial develops and tests a mobile health (mHealth) intervention to improve adherence to lifestyle recommendations in colorectal cancer (CRC) survivors and their family caregivers. The current challenge for cancer survivorship is identifying novel approaches to help adhere to the lifest...
What is the current status of trial NCT06746012?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-05-03. Estimated completion is 2026-12-31.
What conditions does trial NCT06746012 study?
This clinical trial studies the following conditions: Stage III Rectal Cancer AJCC v8, Stage II Rectal Cancer AJCC v8, Stage III Colon Cancer AJCC V8, Stage I Colon Cancer AJCC V8, Stage I Rectal Cancer AJCC V8.
What interventions are being tested in trial NCT06746012?
The interventions under investigation include: Interview (OTHER), Internet-Based Intervention (OTHER), Discussion (PROCEDURE), Educational Activity (OTHER).
Who is sponsoring clinical trial NCT06746012?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06746012 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage III Rectal Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
RECRUITING · Phase 2
-
An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
RECRUITING · Early Phase 1
-
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
RECRUITING · Phase 1
-
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
RECRUITING · Early Phase 1
-
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
RECRUITING
-
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.